NCT07090733 Ultrasound Guided Interscalene, Suprascapular and Anterior Glenoid Nerve Blocks on Diaphragmatic Excursion and Analgesia Following Arthroscopic Shoulder Surgery
| NCT ID | NCT07090733 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Interscalene Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the diaphragmatic movement and postoperative analgesia following anterior glenoid, suprascapular, and interscalene nerve blocks in patients undergoing elective arthroscopic shoulder surgery.
Eligibility Criteria
Inclusion Criteria: * Age from 21 to 65 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I or II. * Scheduled for arthroscopic shoulder surgery. Exclusion Criteria: * Patient's refusal to participate. * Patients with a history of allergy to local anesthetics. * Patients with a history of chronic use of painkillers. * Patients presented with mental dysfunction. * Patients with coagulation disorders. * Patients presented with skin or soft tissue infection at the proposed site of needle Insertion. * Pregnant Patients. * Patients with Chronic Obstructive Pulmonary Disease (COPD) or a Body Mass Index (BMI) of more than 40.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07090733 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 65 Years, studying Interscalene Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07090733 currently recruiting?
Yes, NCT07090733 is actively recruiting participants. Contact the research team at Drfatmaelsamahy@gmail.com for enrollment information.
Where is the NCT07090733 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT07090733 clinical trial?
NCT07090733 is sponsored by Tanta University. The trial plans to enroll 80 participants.